Jim Steinhardt

Jim Steinhardt is a current director at AstraZeneca, where they apply their expertise in the Cell Therapy Unit. Jim previously served as a scientist and senior scientist at AstraZeneca, contributing to various research initiatives. They also worked as a postdoctoral fellow at the Yuxing Li Laboratory, focusing on engineering antibodies for HIV and Ebola. Jim's academic background includes a PhD in Molecular Medicine from the University of Maryland and a degree in Biomedical Engineering from The Johns Hopkins University. Additionally, Jim gained valuable experience as a research assistant in several laboratories, contributing to advancements in cancer research.